National prospective study on the use of local haemostatic agents during partial nephrectomy

Archive ouverte

Lang, Herve | Mouracade, Pascal | Gimel, Pierre | Bernhard, Jean | Pignot, Géraldine | Zini, Laurent | Crépel, Maxime | Rigaud, Jérôme | Salomon, Laurent, J. | Bellec, Laurent | Vaessen, Christophe | Roupret, Morgan | Jung, Jean | Mourey, Eric | Martin, Xavier | Bigot, Pierre | Bruyere, Franck | Berger, Julien | Ansieau, Jean | Salome, Franck | Hubert, Jacques | Pfister, Christian | Trifard, François | Gigante, Marc | Baumert, Hervé | Méjean, Arnaud | Patard, Jean

Edité par CCSD ; Wiley -

International audience. OBJECTIVE:To assess the use of local haemostatic agents (HAs) in a prospective multicentre large series of partial nephrectomies (PNs).PATIENTS AND METHODS:Prospective National Observational Registry on the Practices of Haemostasis in Partial Nephrectomy (NEPHRON): the study was conducted in 54 French urological centres from 1 June to 31 December 2010. In all, 570 consecutive patients undergoing a PN were enrolled in this study in a prospective manner. The data was collected prospectively via an electronic case-report form: five different sheets were included for preoperative, perioperative, postoperative and follow-up data respectively. Information related to haemostasis was analysed.RESULTS:The median patient age was 60 years and the mean (range) tumour size was 3.68 (0.19-15) cm. An HA was primarily used in 71.4% of patients, with a statistically significant difference among surgical approaches (P = 0.024). In 91.8% of cases, a single use of a HA was sufficient for achieving haemostasis. The HA was used either alone (13.9%) or in association with sutures (80.3%). One or more additional haemostatic action(s) was needed in 12.3% of the cases. When comparing patients who received a HA with those who did not receive a HA, there was no statistical difference between the groups for tumour size (P = 0.542), collecting system drainage (P = 0.538), hospital stay (P = 0.508), operation time (P = 0.169), blood loss (P = 0.387) or transfusion rate (P = 0.713).CONCLUSION:HAs are widely used by urologists during PN. Progress is needed for standardising HA application, especially for the timing of application. For the time being, the role of the HA in nephron-sparing surgery is still to be evaluated.

Consulter en ligne

Suggestions

Du même auteur

Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population.

Archive ouverte | Neuzillet, Yann | CCSD

International audience. BACKGROUND: Patients with end-stage renal disease (ESRD) are at risk of developing renal tumours. OBJECTIVE: Compare clinical, pathologic, and outcome features of renal cell carcinomas (RCCs)...

The use of partial nephrectomy: results from a contemporary national prospective multicenter study

Archive ouverte | Pignot, Géraldine | CCSD

International audience

Nephrectomy improves overall survival in patients with metastatic renal cell carcinoma in cases of favorable MSKCC or ECOG prognostic features

Archive ouverte | Mathieu, Romain | CCSD

International audience. Objectives : The role of cytoreductive nephrectomy (CN) in the treatment of patients harboring metastatic renal cell carcinoma (mRCC) has become controversial since the emergence of effective...

Chargement des enrichissements...